December 2022 - Ingenza

Blog entry

Crossing the divide from academia to industry

Posted Dec 19th, 2022 in Blog

Dr Connor Bowen is a Senior Scientist working within the molecular biology team at Ingenza. He received his undergraduate degree from the University of Dundee, and followed it up with a PhD and post doc at the same institution, studying Serratia…

Article

Ingenza enables Scottish SME to bring low-cost haemophilia A treatment a step closer to market

Posted Dec 13th, 2022 in Press releases

Ingenza has delivered a new, proprietary biomanufacturing process for human recombinant factor VIII (rhFVIII) to Scottish biotechnology company ProFactor Pharma Ltd (PFP), which will considerably increase global access to low-cost treatment for haemophilia A. The novel bioprocess underpins PFP’s recent…

News and Events

Crossing the divide from academia to industry

Ingenza enables Scottish SME to bring low-cost haemophilia A treatment a step closer to market